Walleye Capital’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-220,089
| Closed | -$293 | – | 2205 |
|
|
2021
Q3 | $293 | Sell |
220,089
-126,450
| -36% | -$168 | 0.01% | 1000 |
|
|
2021
Q2 | $662 | Buy |
+346,539
| New | +$662 | 0.02% | 622 |
|
|
2020
Q3 | – | Sell |
-58,609
| Closed | -$222K | – | 931 |
|
|
2020
Q2 | $222K | Buy |
+58,609
| New | +$222K | 0.05% | 404 |
|